OPRX - OptimizeRx Corp. Stock Analysis

Stock Taper

SCREENER COMPARE ANY 2 STOCKS

OPRX

OPTIMIZERX CORP.

NASDAQ

$7.71

▼ DOWN 3.14% (-0.25)

KEY STATISTICS

Market Cap$144.68 M

52w High$22.25

52w Low$4.54

Dividend Yield—

Frequency—

P/E7.07

Volume131.49K

Shares Out.18.77M

COMPANY

LEADERSHIP

CHIEF EXECUTIVE

Stephen L. Silvestro

COMPENSATION 2026

Salary$500,000

Stock Awards$752,184

Incentive Plan Pay$627,623

All Other Comp.$3,600

Total$2,717,717

ABOUT

SECTOR

Healthcare

WENT PUBLIC

November 28, 2007

METHOD OF GOING PUBLIC

IPO

FULL TIME EMPLOYEES

133

PRICE TARGET

Target High$12.00

Target Low$7.00

Target Median$11.00

Target Consensus$10.25

UPCOMING EARNINGS

DateNov 5, 2026

DayThursday

Rev. Est.$21.62M

NOV

THU

SPLIT RECORD

DATE	TYPE	RATIO
2018-05-14	Reverse	1:3
2008-04-17	Reverse	1:1000
2008-04-02	Reverse	1:1000
2006-12-18	Forward	6:1

PRICE

$7.71 ▼ DOWN 3.14% (−$0.25)

OVERLAYS

About OptimizeRx Corp.

https://www.optimizerx.com ↗

OptimizeRx Corporation provides digital health solutions—including patient support, brand messaging, and adherence platforms—for life sciences, healthcare providers, and patients to improve medication access and engagement.

INDUSTRY

Medical - Healthcare Information Services

A SERVICE OPTIMIZERX CORP. IS KNOWN FOR

Dynamic Audience Activation Platform (DAAP)

OptimizeRx's AI-driven platform enables pharmaceutical companies to deliver targeted, data-driven marketing messages to healthcare providers and patients via EHR integration, enhancing communication and revenue through predictive analytics and mac...